inositol has been researched along with Coronary Artery Disease in 7 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "LV functional parameters and the reactive hyperemia index also remained unchanged after the 24-week treatment." | 1.48 | Effect of Sitagliptin on Coronary Flow Reserve Assessed by Magnetic Resonance Imaging in Type 2 Diabetic Patients With Coronary Artery Disease. ( Dohi, K; Fujimoto, N; Ishida, M; Ito, M; Kumagai, N; Masuda, J; Moriwaki, K; Nakamori, S; Nakamura, M; Sakuma, H; Sato, Y; Sawai, T; Takeuchi, T; Yamada, N, 2018) |
| "Factors associated with disease progression despite optimal glucose control remain to be elucidated." | 1.40 | Clinical predictors of atheroma progression despite optimal glycemic control in early-stage diabetic patients with coronary artery disease: Insight from the DIANA study. ( Kataoka, Y; Kimura, K; Kosuge, M; Miyamoto, Y; Miyazaki, S; Sase, K; Yasuda, S; Yoshimasa, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Omori, K | 1 |
| Katakami, N | 1 |
| Arakawa, S | 1 |
| Yamamoto, Y | 1 |
| Ninomiya, H | 1 |
| Takahara, M | 1 |
| Matsuoka, TA | 1 |
| Tsugawa, H | 1 |
| Furuno, M | 1 |
| Bamba, T | 1 |
| Fukusaki, E | 1 |
| Shimomura, I | 1 |
| Koyama, T | 1 |
| Tanaka, A | 1 |
| Yoshida, H | 1 |
| Oyama, JI | 1 |
| Toyoda, S | 1 |
| Sakuma, M | 1 |
| Inoue, T | 1 |
| Otsuka, Y | 1 |
| Node, K | 1 |
| Moriwaki, K | 1 |
| Takeuchi, T | 1 |
| Fujimoto, N | 1 |
| Sawai, T | 1 |
| Sato, Y | 1 |
| Kumagai, N | 1 |
| Masuda, J | 1 |
| Nakamori, S | 1 |
| Ishida, M | 1 |
| Yamada, N | 1 |
| Nakamura, M | 1 |
| Sakuma, H | 1 |
| Ito, M | 1 |
| Dohi, K | 1 |
| Kataoka, Y | 2 |
| Yasuda, S | 2 |
| Miyamoto, Y | 2 |
| Sase, K | 2 |
| Kosuge, M | 2 |
| Kimura, K | 2 |
| Yoshimasa, Y | 2 |
| Miyazaki, S | 2 |
| Hiki, M | 1 |
| Shimada, K | 1 |
| Kiyanagi, T | 1 |
| Fukao, K | 1 |
| Hirose, K | 1 |
| Ohsaka, H | 1 |
| Fukushima, Y | 1 |
| Kume, A | 1 |
| Matsumori, R | 1 |
| Sumiyoshi, K | 1 |
| Miyazaki, T | 1 |
| Ohmura, H | 1 |
| Kurata, T | 1 |
| Miida, T | 1 |
| Daida, H | 1 |
| Shimabukuro, M | 1 |
| Masuzaki, H | 1 |
| Sata, M | 1 |
2 trials available for inositol and Coronary Artery Disease
| Article | Year |
|---|---|
Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic p
Topics: 1-Deoxynojirimycin; Aged; Coronary Artery Disease; Coronary Disease; Cross-Over Studies; Diabetes Me | 2010 |
Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early-stage diabetic patients.
Topics: Aged; Coronary Artery Disease; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Female; Glyc | 2012 |
5 other studies available for inositol and Coronary Artery Disease
| Article | Year |
|---|---|
Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS.
Topics: Aged; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Coronary Artery Disease; Diabetes | 2020 |
Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, pilot study (EFFORT).
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endothel | 2018 |
Effect of Sitagliptin on Coronary Flow Reserve Assessed by Magnetic Resonance Imaging in Type 2 Diabetic Patients With Coronary Artery Disease.
Topics: Aged; Coronary Artery Disease; Coronary Circulation; Diabetes Complications; Diabetes Mellitus, Type | 2018 |
Clinical predictors of atheroma progression despite optimal glycemic control in early-stage diabetic patients with coronary artery disease: Insight from the DIANA study.
Topics: Blood Glucose; Coronary Angiography; Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus; Disea | 2014 |
Intensive glucose lowering in cardiovascular risk management - unsolved questions - .
Topics: Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus; Female; Glycemic Index; Humans; Inositol; | 2012 |